Changeflow GovPing Pharma & Drug Safety Ikaros Zinc Finger Degraders and Uses Thereof
Routine Notice Added Final

Ikaros Zinc Finger Degraders and Uses Thereof

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Published March 25th, 2026
Detected April 2nd, 2026
Email

Summary

The European Patent Office published Gilead Sciences' patent application EP4452414A2 for Ikaros zinc finger family degraders and their therapeutic uses. The patent covers heterocyclic compounds (C07D) with applications in cancer treatment (A61P 35/00). Designated states include all EU member states plus additional European countries.

What changed

The EPO published Gilead Sciences' patent EP4452414A2 for Ikaros zinc finger family degraders and uses thereof on March 25, 2026. The patent covers heterocyclic compounds classified under multiple C07D subclasses and specifies therapeutic uses primarily for cancer treatment (A61P 35/00). The designated contracting states include all EU member states along with other European countries.

This is a routine patent publication with no compliance obligations. Competitors developing targeted protein degradation therapies should review the patent claims for freedom-to-operate considerations. The patent establishes intellectual property protection for Gilead's degrader compounds but does not create regulatory requirements for other market participants.

Source document (simplified)

← EPO Patent Bulletin

IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF

Publication EP4452414A2 Kind: A2 Mar 25, 2026

Applicants

GILEAD SCIENCES, INC.

Inventors

BALAN, Gayatri, BLOMGREN, Peter A., CODELLI, Julian A., DU, Zhimin, KIM, Musong, THOMAS-TRAN, Rhiannon, TUDESCO, Michael T., VENKATARAMANI, Chandrasekar

IPC Classifications

A61P 35/00 20060101AFI20260218BHEP C07D 401/04 20060101ALI20260218BHEP C07D 401/12 20060101ALI20260218BHEP C07D 401/14 20060101ALI20260218BHEP C07D 405/14 20060101ALI20260218BHEP C07D 471/08 20060101ALI20260218BHEP A61K 31/454 20060101ALI20260218BHEP A61K 31/4545 20060101ALI20260218BHEP A61K 31/4748 20060101ALI20260218BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4452414A2

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Publication
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Healthcare

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.